Titan Pharmaceuticals Announces Pricing of $9.7 Million Registered Direct OfferingPRNewsWire • 01/15/21
Titan Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public OfferingPRNewsWire • 10/28/20
Titan Pharmaceuticals News: 8 Things for TTNP Stock Investors to Know about the JT Pharma DealInvestorPlace • 10/28/20
Titan Pharmaceuticals Announces Debt Settlement Agreement with Molteni and HorizonPRNewsWire • 10/26/20
Titan Pharmaceuticals' Stockholders Approve Proposal To Amend Its Certificate Of IncorporationPRNewsWire • 09/18/20
Titan Pharmaceuticals Provides Update To Stockholders On Proposal To Amend Its Certificate Of IncorporationPRNewsWire • 09/14/20
Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/14/20
Titan Pharmaceuticals To Report Second Quarter 2020 Financial Results On August 14, 2020PRNewsWire • 08/10/20
Titan Pharmaceuticals Urges Stockholders to Vote "FOR" Proposal to Amend Its Certificate of IncorporationPRNewsWire • 07/08/20
Titan Pharmaceuticals And Indegene Enter Into Probuphine® Co-Promotion PartnershipPRNewsWire • 06/24/20
Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/16/20
Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/30/20
Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/15/19
Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/15/19
Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/16/19
Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q4 2018 Results - Earnings Call TranscriptSeeking Alpha • 04/02/19